Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | GBA1 | P04062 | 3/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16183603 | 0.90 | ALDH1A1 (0.52) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14727723 | 0.83 | ABCG2 (0.49) | RXFP1MEN1ALDH1A1KMT2AMAPK1 | |
| SCHEMBL16183605 | 0.80 | TSHR (0.50) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL16183602 | 0.79 | TSHR (0.59) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14727832 | 0.78 | CYP1A2 (0.61) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14727835 | 0.74 | ALDH1A1 (0.53) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14475084 | 0.73 | CYP1A2 (0.52) | MEN1ALDH1A1KMT2AKDM4EMAPK1 | |
| SCHEMBL14727976 | 0.72 | CYP1A2 (0.65) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL16186207 | 0.72 | CYP11B2 (0.48) | RXFP1ALDH1A1KDM4EMAPK1TSHR | |
| SCHEMBL16183846 | 0.72 | ABCG2 (0.48) | RXFP1MEN1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140315886-A1 | QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
| US-20140315886-A1 | QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315886-A1 | QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE | PPP2CA, PPP4C, PPP3CB | RXFP1 3202/4885MEN1 4814/4885ALDH1A1 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.